The app aims to support French people with diabetes during the Covid-19 pandemic through three main ways:
After joining, you can:
“CoviDIAB is the new online application that will allow you to have clear, verified answers and personalised practical advice during this period of COVID-19 epidemic: to reassure you and support you in managing your daily life with diabetes.
This can be a supplement to all the advice that the French Federation of Diabetics (Fédération Française des diabétiques) sends you daily.…CoviDIAB is a web program which allows people with diabetes to stay informed in a reliable and validated way (daily updates), about their health.
This collaborative program is led by doctors and hospital carers, and supported by the AP-HP (Assistance Publique - Hôpitaux de Paris) and INSERM research teams (National Institute for Medical Research).
All the contents of this program have been validated by doctors and comply with official recommendations concerning the coronavirus.
CoviDIAB is a web application accessible on your smartphone, tablet or computer.No app or software to install: simply create your account online at: https://covidiab.fr/”
PatientView provides this website for use as information, or for educational purposes. We do not warrant that the information we provide on the website will meet your health or medical requirements. Contact a health professional if you are concerned about your health. Nor can we guarantee that the information we provide on the website will always be up to date or accurate. PatientView is providing details of apps recommended by patient groups, an act which does not imply PatientView’s endorsement of any app. PatientView is not responsible for third-party content. Read more for copyright considerations